IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork

被引:38
|
作者
Hosseini, M
Rose, AY
Song, KL
Bohan, C
Alexander, JP
Kelley, MJ
Acott, TS
机构
[1] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97239 USA
[2] Triple Point Biol, Forest Grove, OR USA
关键词
D O I
10.1167/iovs.05-0451
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. The cytokines TNF and IL-1 mediate the MMP-3 increase that occurs in response to trabecular meshwork (TM) treatment by laser trabeculoplasty. This MMP-3 increase appears to play a key role in the efficacy of this treatment for open-angle glaucoma. Protein kinase C mu and the Erk mitogen-activated protein (MAP) kinases are essential signaling components in transducing MMP-3 increases produced by treatment of TM cells with these cytokines. Here, the involvement of the JNK-MAP kinase pathway in this process was evaluated. METHODS. Porcine TM cells were treated with TNF alpha, IL-1 alpha, or IL-1 beta. Changes in MMP-3 and MMP-9 protein levels in the media were then determined by Western immunoblot. The effect of JNK inhibitor 2 was evaluated. Changes in the level of phosphorylation of JNK, c-Jun, ATF-2, MKK4, and MKK7 were also determined at various times after TNF alpha or IL-1 alpha treatment. A 2.3-kb MMP-3 promoter fragment was cloned into a secreted alkaline phosphatase reporter vector. This reporter construct was cotransfected into TM cells with a mammalian expression vector containing a dominant-negative mutant of JNK. The involvement of JNK activity in the TNF alpha and IL-1 alpha induction of MMP-3 expression was then evaluated. RESULTS. TNF alpha, IL-1 alpha, and IL-10 increase media MMP-3 and MMP-9 protein levels, and JNK inhibitor 2 blocks these increases. JNK1/2, MKK4, c-Jun, and ATF-2 phosphorylation levels increase in response to TNF alpha and IL-1 alpha treatment. JNK inhibitor 2 pretreatment blocks these c-Jun and ATF-2 phosphorylation increases. Dominant-negative JNK dramatically reduces the MMP-3 promoter-driven reporter activity induced by these cytokines. CONCLUSIONS. JNK activity is necessary for the induction of MMP-3 and MMP-9 by TNF alpha, IL-1 alpha, or IL-1 beta in TM cells. Phosphorylation of components of the JNK signaling pathway and of the transcription factors c-Jun and ATF-2 support a role for this pathway in the induction of MMP-3 and MMP-9 in the TM in response to these cytokines. Thus, at least three separate signal transduction pathways are necessary in this signaling event in TM cells.
引用
收藏
页码:1469 / 1476
页数:8
相关论文
共 50 条
  • [31] c-Jun N-Terminal Kinase 1 Is Required for the Development of Pulmonary Fibrosis
    Alcorn, John F.
    van der Velden, Jos
    Brown, Amy L.
    McElhinney, Brian
    Irvin, Charles G.
    Janssen-Heininger, Yvonne M. W.
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2009, 40 (04) : 422 - 432
  • [32] Induction of matrix metalloproteinase-2 by tenascin-X deficiency is mediated through the c-Jun N-terminal kinase and protein tyrosine kinase phosphorylation pathway
    Matsumoto, K
    Minamitani, T
    Orba, Y
    Sato, M
    Sawa, H
    Ariga, H
    EXPERIMENTAL CELL RESEARCH, 2004, 297 (02) : 404 - 414
  • [33] Deficiency of c-Jun N-Terminal Kinase-1 enhances IL-10 production in macrophages
    Azuma, YT
    Tran, E
    Takeuchi, T
    Flavell, R
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 : 93P - 93P
  • [34] c-Jun N-terminal kinase is involved in motility of endothelial cell
    Eun-Young Shin
    Seok-Yong Kim
    Eung-Gook Kim
    Experimental & Molecular Medicine, 2001, 33 : 276 - 283
  • [35] c-Jun N-terminal kinase mediates apoptosis in human eosinophils
    Kares, H
    Zhang, X
    Moilanen, E
    Kankaanranta, H
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 197 (03) : 177 - 177
  • [36] Role of C-Jun N-terminal Kinase in Hepatocellular Carcinoma Development
    Wang, Juan
    Tai, Guixiang
    TARGETED ONCOLOGY, 2016, 11 (06) : 723 - 738
  • [37] The c-Jun N-terminal kinase pathway and apoptotic signaling (review)
    Chen, YR
    Tan, TH
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 16 (04) : 651 - 662
  • [38] Pathophysiological significance of c-jun N-terminal kinase in acetaminophen hepatotoxicity
    Du, Kuo
    Xie, Yuchao
    McGill, Mitchell R.
    Jaeschke, Hartmut
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (11) : 1769 - 1779
  • [39] c-Jun N-Terminal Kinase Pathway Inhibition in Intracerebral Hemorrhage
    Michel-Monigadon, Delphine
    Bonny, Christophe
    Hirt, Lorenz
    CEREBROVASCULAR DISEASES, 2010, 29 (06) : 564 - 570
  • [40] c-Jun N-terminal kinase is involved in motility of endothelial cell
    Shin, EY
    Kim, SY
    Kim, EG
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2001, 33 (04): : 276 - 283